Scleroderma Clinical Trials

A listing of Scleroderma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-na ve Obsessive-compulsive Disorder(OCD)

This study will evaluate the possible therapeutic effects of Transcranial Direct Current Stimulation (tDCS) in drug-nave obsessive-compulsive disorder (OCD) patients, and the underlying neural mechanism by magnetic resonance imaging (MRI),transcranial magnetic stimulation and electroencephalography (TMS-EEG).

transcranial direct current stimulation
MRI
transcranial magnetic stimulation
  • 4 views
  • 17 Sep, 2021
  • 1 location
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

The primary objective is to confirm the incidence of adverse drug reactions (focus on gastrointestinal symptoms including diarrhoea and nausea) to Ofev Capsules seen in clinical trials with real world data generated in patients with SSc-ILD.

nintedanib
progressive systemic sclerosis
scleroderma
pulmonary disease
  • 0 views
  • 15 Sep, 2021
  • 1 location
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures …

other disease
rare diseases
  • 4 views
  • 08 Sep, 2021
  • 2 locations
Metabolomic Analysis of Systemic Sclerosis

Currently investigators do not have diagnostic and prognostic markers for SSc which almost always starts with a vascular disease (Raynaud's disease) isolated for several years. The primary purpose is to highlight discriminating metabolic profiles depending on the characteristics of the disease, allowing early diagnosis of SSc at the onset of …

raynaud's phenomenon
infarct
scleroderma
myocardial infarction
raynaud phenomenon
  • 196 views
  • 11 Sep, 2021
  • 5 locations
Assessment of Nutritional Status in Systemic Sclerosis

The main theme of the cohort of systemic sclerosis (SSc) patients is the determination of nutritional status, its evolution and the evaluation of its management in patients with scleroderma.

scleroderma
pulmonary function test
progressive systemic sclerosis
rheumatism
  • 42 views
  • 08 Sep, 2021
  • 1 location
Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension

Systemic sclerosis (SSc, AKA scleroderma) is an autoimmune condition characterized by endothelial damage and progressive fibrosis of the skin and internal organs. One of the leading causes of

systemic sclerosis
scleroderma
progressive systemic sclerosis
fibrosis
autoimmune disease
  • 12 views
  • 16 Sep, 2021
  • 1 location
Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)

hypothesize that at time of diagnosis the VOC profiles will discriminate patients with PAH-CTD and idiopathic PAH (IPAH) from patients with systemic sclerosis or systemic lupus erythematosus (CTD) without PAH

lupus
progressive systemic sclerosis
rheumatism
connective tissue disease
hypertension
  • 1 views
  • 15 Sep, 2021
  • 1 location
NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD SSc-ILD IPF) Who Start Treatment With Nintedanib.

To better understand the clinical characteristics of Idiopathic Pulmonary Fibrosis (IPF) / Systemic Sclerosis-associated-Interstitial Lung Disease (SSc-ILD)/ Progressive Fibrosing Interstitial

interstitial lung disease
progressive systemic sclerosis
nintedanib
ofev
idiopathic pulmonary fibrosis
  • 0 views
  • 16 Sep, 2021
  • 28 locations
New Orleans Pulmonary Hypertension Biobank

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure >=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The …

systemic sclerosis
progressive systemic sclerosis
rheumatism
hypertension
mixed connective tissue disease
  • 102 views
  • 15 Sep, 2021
  • 1 location
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy

BACKGROUND Sjgren's syndrome is an autoimmune disease whose prevalence is estimated between 200 and 500 patients per 100,000 persons in France (120 to 500,000 patients). It affects women (90%) between 40 and 60 years of age and main manifestations are generalized sicca syndrome (ocular, oral, cutaneous) and arthralgia. In 20% …

numbness
analgesics
skin biopsy
  • 0 views
  • 05 Sep, 2021
  • 2 locations